The American Journal of Managed Care5 天
Visual Acuity Enhanced in Patients With DME, RVO With Foveal Bulge
Patients with a foveal bulge had significantly enhanced visual acuity if they also had resolved diabetic macular edema (DME) ...
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...
Finanznachrichten6 天
Ocular Therapeutix, Inc.: Ocular Therapeutix Shares SOL-R Enrollment Progress and Next ...
311 subjects enrolled across various stages of loading and randomization in SOL-R, Ocular's second registrational trial of AXPAXLI in wet AMD, as of January 10, 2024 First wet AMD registrational trial ...